G1 Therapeutics J-Code Announcement
Modi tempora incidunt
March 9, 2021The National Comprehensive Cancer Network® (NCCN®) revised its guidelines
January 27, 2023G1 Therapeutics, Inc. secures permanent J Code for COSELA™ (trilaciclib). The code, J1448, is effective on October 1, 2021. Visit COSELA.com for more information.